Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria
about
Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, propertiesHuman CAP18: a novel antimicrobial lipopolysaccharide-binding proteinAntimicrobial photodynamic therapy to kill Gram-negative bacteriaThe carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexesPotential applications of N-terminal recombinant fragments of bactericidal/permeability-increasing protein in liver surgery.A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blooExtracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.Antimicrobial activity of peptides derived from olive flounder lipopolysaccharide binding protein/bactericidal permeability-increasing protein (LBP/BPI)New therapies and vaccines for meningococcal disease.Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils.Impaired innate immunity at birth: deficiency of bactericidal/permeability-increasing protein (BPI) in the neutrophils of newborns.Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobialsSynergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing proteinLoss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxinEffect of anticoagulants on binding and neutralization of lipopolysaccharide by the peptide immunoglobulin conjugate CAP18(106-138)-immunoglobulin G in whole bloodUse of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosaProtection of mice from lethal Escherichia coli infection by chimeric human bactericidal/permeability-increasing protein and immunoglobulin G1 Fc gene deliveryEffect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coliA killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.Antimicrobial activity of rabbit CAP18-derived peptides.Extraintestinal pathogenic Escherichia coli survives within neutrophils.An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein.Bacteria in the intestine, helpful residents or enemies from within?Mouse eosinophils possess potent antibacterial properties in vivo.Importance of the residue 190 on bactericidal activity of the bactericidal/permeability-increasing protein 5.Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis.The bactericidal/permeability-increasing protein (BPI) in the innate defence of the lower airways.Acute bacterial meningitis in infants and children: epidemiology and management.Endothelial adhesion molecule expression and its inhibition by recombinant bactericidal/permeability-increasing protein are influenced by the capsulation and lipooligosaccharide structure of Neisseria meningitidisImmune modulation by bacterial outer membrane vesicles.Apoptotic Cell Death Induced by ofLBP6A, Lipopolysaccharide Binding Protein Model Peptide, Derived from Paralichthy olivaceus on MKN-28 Cells.Bactericidal/permeability-increasing protein inhibits growth of a strain of Acholeplasma laidlawii and L forms of the gram-positive bacteria Staphylococcus aureus and Streptococcus pyogenes.Arginine-rich cationic polypeptides amplify lipopolysaccharide-induced monocyte activation
P2860
Q24530088-575EBC99-DDB2-4053-9D8C-E22D7F2DD0A7Q24682905-34431E8C-83D3-4982-8709-1A7413C2E414Q26866247-61D9A156-E614-47F8-A857-0EBFB530A3B4Q28214380-C4613233-2674-4C16-B75A-76638FCD4243Q33539885-861BFB5C-56EA-44A2-99E7-2E6D51F343FDQ33593645-AF7BE9A4-7E39-4535-87C5-4DB9B09A638AQ33599033-115D2E4A-A469-44F5-8D29-E4F0551D0B89Q34212308-AD7478BF-5F36-4092-BC49-67E99C50474EQ34229105-3449CFFD-BB8C-477E-8A28-8D04673A6697Q34411550-19B5D419-DA57-4B50-A060-7FB7A8F55FACQ34481640-A7B84616-8A5A-4579-A3DA-F9C0290FD82AQ34528895-28ACD57C-199E-4398-8AE8-57E3C7F37BF1Q34658119-E5228B6E-AA9D-4895-999B-85DE93CE726BQ34775371-515764F6-B1DA-4676-A505-205B6ABFF144Q35121455-8C38A17F-FEAB-4B3E-A706-987B97B12357Q35176262-B9E14C06-CDAA-4670-860C-C38336C68651Q35381513-CF947DF2-0B96-4EDE-9CF6-EDE86211FC72Q35399021-1505AC22-E000-4E15-A38F-9B54F8E7E777Q35502327-FDD606B6-2104-4C70-B57E-6F2ABFFC2969Q35516570-16001837-1EAB-4777-973A-EBDC25AF0100Q35548846-8F33A708-D7FE-49FE-ACCC-B5383EEE3E5AQ35632357-E13088AE-2A97-4DCE-82DE-D27FA1CCD9BEQ35635915-1AD0DBC3-F5D4-452E-B3CB-2C11A7E2F1ABQ35771793-270EC4D2-B056-46E1-8C18-A75639CDB3A2Q35878788-7CD236A3-2EE3-4F1A-976C-6F79E9C9BE77Q35903904-65203E79-AF58-482B-B9C6-915D94E6F5ECQ35913545-1AC810A2-1A5D-4E0A-A682-0ADEE643497CQ36603406-D01CCC18-6FCE-46A4-998C-F02789F646F5Q36628085-8C1C5DA7-8748-459F-9EA5-438480B6EF4AQ36804240-44A08CF3-1536-4FB9-B5F9-8E517FEB68D0Q37410325-B02342CB-ADBE-4359-B320-D82BDF4A6D87Q37536487-0E2DE7D3-9D82-4689-8825-B4B219606872Q37879190-307FF0B9-8E45-494D-AFE7-348375A8452FQ37905157-A8865EA4-5D81-4A75-9E0C-BF781E99657DQ37945754-6544F02E-5AA2-48BF-BD25-53596CCBA136Q38319197-970895A0-AE44-45FE-81CD-CF96701C0B28Q38481554-6AF2F4B3-A4C7-4FFF-81D0-4D2A9B2564F7Q38783727-FB62E015-CB27-4DAB-A3EB-623B7D1B8DF2Q39471806-D4C72F08-8D05-4AD7-8365-D4E163B7BBDAQ39672321-19D9249F-701E-471B-B12D-35B6C6A7DDC7
P2860
Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Human bactericidal/permeabilit ...... elease induced by the bacteria
@ast
Human bactericidal/permeabilit ...... elease induced by the bacteria
@en
type
label
Human bactericidal/permeabilit ...... elease induced by the bacteria
@ast
Human bactericidal/permeabilit ...... elease induced by the bacteria
@en
prefLabel
Human bactericidal/permeabilit ...... elease induced by the bacteria
@ast
Human bactericidal/permeabilit ...... elease induced by the bacteria
@en
P2093
P2860
P356
P1476
Human bactericidal/permeabilit ...... elease induced by the bacteria
@en
P2093
J Castillo
P2860
P304
P356
10.1172/JCI115930
P407
P577
1992-09-01T00:00:00Z